Skip to content

Clinical trials

Prostatic Neoplasms, Castration-Resistant trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20171
20182
20192
20201
20233
20244
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Active, not recruiting4
Completed4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC6
Hoffmann-La Roche2
MacroGenics2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Aragon Pharmaceuticals, Inc.1
Astellas Pharma Global Development, Inc.1
Boehringer Ingelheim1
Celcuity Inc1
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant20
Neoplasms3
Prostatic Neoplasms3
Genital Diseases, Male2
Lymphoma, Non-Hodgkin2
Male Urogenital Diseases2
Neoplasms by Site2
Prostatic Diseases2
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.